ACTU: מזומנים בחישוב למניה אחת Actuate Therapeutics Inc

Actuate Therapeutics, Inc. (ACTU) is optimizing the delivery of oncology drugs through specialized cold chains, which enhances operational efficiency. The net cash position per share reflects liquidity dynamics, with the metric settling at 0.03. However, the lack of revenue and reliance on investments create risks. At the same time, its independence from macroeconomic factors makes this biotech asset a resilient defensive instrument.
פילוחי מדדים מקיפים ואנליטיקה עבור Actuate Therapeutics (ACTU)

Cash per share measures the issuer's net liquidity, determining the actual cash reserve per unit of equity to assess financial stability. By analyzing the cash position per share on GURU.Markets, an investor separates the operational strength of Actuate Therapeutics, Inc. (ACTU) from market noise, which is critical for funding the development of targeted drugs until monopoly profits are realized.